With Bharat Biotech planning to ramp up its capacities for vaccine productions, Borosil could be a major beneficiary.
The stock has just completed a breakout retest and we could look for a bounce from here. (buy only if it bounces, else we'll look for a bounce around 206) Long after bounce around current price. SL below 205. I would double my allocation above the marked price of 245 for much higher targets.
Le informazioni ed i contenuti pubblicati non costituiscono in alcun modo una sollecitazione ad investire o ad operare nei mercati finanziari. Non sono inoltre fornite o supportate da TradingView. Maggiori dettagli nelle Condizioni d'uso.